I agree Hottin, as long as emh is potentially one of the lowest cost producers, and the metallurgical path taken is to the benefit of emh shareholders.
Let's wait and see the numbers, and whatever other news may follow.
- Forums
- ASX - By Stock
- EMH
- PFS
PFS, page-32
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EMH (ASX) to my watchlist
|
|||||
Last
27.0¢ |
Change
-0.020(6.90%) |
Mkt cap ! $56.01M |
Open | High | Low | Value | Volume |
26.5¢ | 27.0¢ | 26.5¢ | $6.448K | 24.01K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 34878 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 0.270 |
3 | 100111 | 0.265 |
1 | 9214 | 0.260 |
2 | 10639 | 0.255 |
5 | 46574 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.300 | 34878 | 1 |
0.305 | 6370 | 1 |
0.310 | 8148 | 1 |
0.325 | 3000 | 1 |
0.330 | 28480 | 4 |
Last trade - 10.05am 15/07/2024 (20 minute delay) ? |
Featured News
EMH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online